Invitation

Scientific Programme

General Information

Accreditation

Mon 09.12 – Tue 10.12.2024

City: London

Invitation

Dear Colleagues

It is a real pleasure to announce the 8th Christmas Postgraduate Course of the Royal Brompton and Harefield NHS Foundation Trust & Imperial College, the Cardiology Update London.

Cardiology and cardiovascular medicine in general is a rapidly expanding field with impressive developments and innovations over the last years. For physicians, be it general practitioners, cardiologists or cardiac surgeons, it is therefore important to keep pace with a challenging environment. To that end, we have designed a postgraduate course, the Cardiology Update London, to summarize, at the end of the year, the most important new developments, innovations, but also failures that will all affect cardiovascular diagnosis and management in our everyday practice.

We have selected an international Faculty of high standing experts both from the Trust and worldwide, covering the broad spectrum of cardiovascular medicine from prevention to intervention, from valvular heart disease to heart failure, and from conservative management to intervention and surgical operations. Thus, the course will give an up-to-date overview about current diagnosis and management of the most important cardiovascular conditions during two days in London.

We would be most happy to welcome you at the Royal Society of Medicine in central London to enjoy two days of interactive education for the benefit of your practice and your patients.

Prof. Thomas F. Lüscher
MD, FRPC, FESC

Dr. Peter Libby
FESC, FACC

Prof. Bernard J. Gersh
FACC

Dr. Richard Grocott-Mason
MD, FRCP

Dr. Eleanor Wicks
FESC

---

Scientific Programme

Monday, December 9^th, 2024 (UK time)

Venue: The Royal Society of Medicine

08:30 | Welcome Address
	Welcome by the ESC President		Thomas F. Lüscher, London

08:45 | Opening Lectures: Frontiers in Cardiovascular Science Chair: Thomas F. Lüscher, London and Filippo Crea, Rome
08:45	Opening Lectures 1: Obesity: Managing an epidemic	John E. Deanfield, London
09:15	Opening Lecture 2: Artificial intelligence in cardiovascular medicine	Thomas F. Lüscher, London
09:45- 10:15	Coffee Break

10:15 | Session 1: Risk Factors and Prevention Chairs: John E. Deanfield, London and Andrew Krentz, London
10:15	Global risk factor assessment	Christina Magnussen, Hamburg
10:35	Genomics of cardiovascular risk factors	Heribert Schunkert, Munich
10:55	Unmet needs in lipid management	Lale Tokgözoğlu, Ankara
11:15	Role of triglycerides as residual CV risk	Peter Libby, Boston
11:35	Diabetes: SGLT2 inhibitors, GLP1/GIP or both? (virtual talk)	Nikolaus Marx, Aachen
11:55	Panel Discussion	All speakers from the session

12:30 – 13:15 | Industry-Sponsored symposium
13:15-14:00 Lunch Buffet

14:00 | Session 2: Hypertension Chairs: Sofie Brouwers, Aalst and Vikas Kapil, London
14:00	Blood Pressure Management: The new 2024 ESC Hypertension Guidelines	John William McEvoy, Galway
14:20	New innovations in drug therapy for hypertension	Gianluigi Savarese, Stockholm
14:40	Update on renal nerve ablation: Recommendations  by the ESC and NICE	Sofie Brouwers, Aalst
15:00	Panel Discussion	All speakers from the session

15:15-15:45 Coffee Break

15:45 | Session 3: Imaging / Chronic Coronary Syndromes Chairs: Richard Grocott-Mason, London and Peter Libby, Boston
15:45	Coronary imaging towards a non-stop shop	Charalambos Antoniades, Oxford
16:05	Photon-based CT: What is the clinical impact?	Stephan Achenbach, Erlangen
16:25	The new 2024 ESC Guidelines on  Chronic Coronary Syndromes	Felicita Andreotti, Rome
16:45	The need for new trials of old drugs: Betablockers and ACEi/ARB	Bernard J. Gersh, Rochester MN
17:05	Heart Failure drugs in patients with Myocardial Infarction	Peter van der Meer, Groningen
17:25	Panel discussion	All speakers from the session
17:45    Cross-functional Networking Reception

---

Tuesday, December 10^th, 2024 (UK Time)

Venue: The Royal Society of Medicine

08:30 | Session 4: Acute Coronary Syndromes and Cardiogenic Shock Chairs: Felicita Andreotti, Rome and Shrilla Banerjee, Redhill
08:30	Update on plaque rupture and erosion	Peter Libby, Boston
08:50	Coagulation and fibrinolysis as prognostic factors after ACS	Diana Gorog, London
09:10	Multivessel ACS: Culprit artery only or complete revascularisation?	Marco Roffi, Geneva
09:30	Cardiogenic shock: Balancing benefit and harm of LV unloading	Christian Hassager, Copenhagen
09:50	DAPT versus SAPT after ACS: Update from recent trials	Robert Byrne, Dublin
10:10	Panel discussion	All speakers from the session

11:00 | Session 5: Valvular Heart Disease Chairs: Alison Duncan, London and NN
11:00	TAVI versus SAVR: Which strategy in routine clinical practice?	Bernard Prendergast, London
11:20	Intervening in aortic stenosis: When is the right time?	Thomas F. Lüscher, London
11:40	Assessing the tricuspid valve	Jeroen J. Bax, Leiden
12:00	Tricuspid valve disease	Ralph S. von Bardeleben, Mainz
12:20	Panel discussion	All speakers from the session

12:30 – 13:15 | Industry-Sponsored Symposium
13:15-14:00    Lunch Buffet

14:00 | The Paul Hamilton Wood Lecture
14:00						The spectrum of Acute Coronary Syndromes						Filippo Crea, Rome

14:30 | Session 6: Atrial Fibrillation and Heart Failure  Chairs: Roxy Senior, London and Theresa McDonagh, London
14:30	Managing atrial fibrillation: The 2024 ESC Guidelines	Isabelle van Gelder, Groningen
14:50	Stroke prevention: LA occlusion or anticoagulation or both? (virtual talk)	Ulf Landmesser, Berlin
15:10	HF, diabetes and renal disease:  The cardiometabolic conundrum (virtual talk)	Nikolaus Marx, Aachen
15:30	Panel discussion	All speakers from the session
15:45 – 16:15 Coffee Break

16:15 | Session 7: Cardiomyopathies Chairs: Bernard J. Gersh, Rochester MN and Eleanor Wicks, Oxford
16:15	New Classification of cardiomyopathies: What does it mean for clinical practice?	Eleanor Wicks, Oxford
16:35	Amyloid heart disease	Martha Grogan, Rochester MN
16:55	Cardiac sarcoidosis	Rakesh Sharma, London
17:15	Panel discussion	All speakers from the session
17:30	Wrap-up and Adjourn	Thomas F. Lüscher, London

This event is supported by the pharmaceutical industry through sponsorship and the purchase of exhibition stand space. Sponsoring companies have no influence or are involved in the meeting programme, selection of speakers or venue.

AstraZeneca has provided a sponsorship towards this independent Programme.
AstraZeneca has had no editorial input into or control over the agenda, content development or choice of speakers, nor opportunity to influence except for the AstraZeneca sponsored symposia presentations.

---

General Information

Registration

Category
Registration fees
Regular fee	GBP 300
Early registration fee (until November 8, 2024)	GBP 250
Trainees/Residents, Research fellows, Nurses, Students <40 years (ID proof required)*	GPB 150
Early registration fee (until November 08, 2024)	GBP 100
Day Tickets	GPB 150

*For the reduced registration (Trainees/Residents, Research fellows, Nurses, Students <40 years) please send a copy of your ID to Ms. Nadine-Estelle Abea at nadine-estelle.abea@zhh.ch

Registration will be confirmed upon receipt of payment.
Please note that UK banks may charge high fees for international bank transfers. We therefore recommend payment by credit card.

Modification & Cancellation

All modifications or cancellations must be notified in writing (by mail, fax or e-mail) to Zurich Heart House. For each modification requested by the participant, GBP 15 will be charged for administrative costs. In case of cancellation up to November 1st, 2024, deposits will be refunded less 35% for administrative costs. After this date, no refund will be possible.

Venue

The Royal Society of Medicine,
1 Wimpole St, Marylebone, London W1G 0AE, United Kingdom

Organisation

London Heart London – Foundation for Cardiovascular Research and Education
Dr. Eleanor Wicks
Nadine-Estelle Abea
www.cardiologyupdate.uk

---

Accreditation

The Cardiology Update London is recognised by the following institutions as accredited continuing education:

-British Cardiovascular Society (submitted)

-Federation of the Royal Colleges of Physicians of the United Kingdom for CPD credits 14 category 1 (external) CPD credits

-EACCME-UEMS European Accreditation Council for Continuing Medical Education (EACCME®) 13 European CME credits (ECMEC®s)

---

Teaching Faculty

---

Sponsors

In collaboration with

jsahggd

khjhlj

fjhd

trgertr

Under the Auspices of

sdghf

hjkhk

dfdfe

Register here